-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Initiates Coverage On Neumora Therapeutics with Outperform Rating, Announces Price Target of $8

Benzinga·01/12/2026 12:44:29
Listen to the news
Leerink Partners analyst Marc Goodman initiates coverage on Neumora Therapeutics (NASDAQ:NMRA) with a Outperform rating and announces Price Target of $8.